Mesalamine

Rank #149 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$109.3M

Total Cost

Share:

176,079

Total Claims

$109.3M

Total Cost

7,734

Prescribers

$621

Cost per Claim

14,220

Beneficiaries

300,549

30-Day Fills

$14K

Avg Cost/Provider

23

Avg Claims/Provider

Share of Medicare Part D Spending

0.04%

of total Medicare Part D spending

$109.3M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $109.3M total

🔎 Data Overview

👤

Average cost of $7,686 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Mesalamine

#ProviderSpecialtyLocationClaimsCost
1Dilip DesaiGastroenterologyFlint, MI133$202K
2William PetersonGastroenterologySpringfield, IL189$200K
3Bradley SklarGastroenterologyUtica, NY128$157K
4Myron BrandGastroenterologyNew Haven, CT168$153K
5David BurnsRheumatologyHouston, TX137$132K
6Xiandong ShiInternal MedicineFlushing, NY201$129K
7Kristen BoardmanPhysician AssistantAnn Arbor, MI109$128K
8Sarah MohammadiPhysician AssistantRochester, NY93$128K
9Jesse StondellGastroenterologySacramento, CA109$123K
10George ChristophiGastroenterologySaint Louis, MO171$120K
11Azzam MuftahGastroenterologyBrooksville, FL110$119K
12Darren SerilGastroenterologyNew Brunswick, NJ140$115K
13Jeffrey GoldsteinGastroenterologyRochester, NY139$112K
14Ashwin AnanthakrishnanGastroenterologyBoston, MA104$112K
15Michael TendlerGastroenterologyMarlboro, NJ107$111K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
146Bupropion Hcl (Bupropion Hcl Sr)$110.0M3,323,724
147Dimethyl Fumarate (Dimethyl Fumarate)$109.8M29,208
148Immun Glob G(Igg)/Gly/Iga 0-50 (Gammaplex)$109.6M7,815
149Mesalamine (Mesalamine)$109.3M176,079
150Axitinib (Inlyta)$109.1M5,937
151Ipratropium/Albuterol Sulfate (Combivent Respimat)$108.3M353,594
152Relugolix (Orgovyx)$107.3M38,821

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology